Logo image
Extended spectrum cephalosporins and Clostridium difficile
Journal article   Peer reviewed

Extended spectrum cephalosporins and Clostridium difficile

C.L. Golledge, T. McKenzie and T.V. Riley
Journal of Antimicrobial Chemotherapy, Vol.23(6), pp.929-931
1989
url
Link to Published Version *Subscription may be requiredView

Abstract

There is little information about how commonly the newer cephalosporins cause diarrhoea due to Clostridium difficile. In this study of 111 patients with C. difficile-associated diarrhoea, 106 had received antimicrobial agents in the four weeks before detection of C. difficile. The relative risk for each antimicrobial agent was greatest with clindamycin, followed by cefotaxime, cephamandole and ceftriaxone. There was no statistically significant difference in risk between the cephalosporins evaluated. Narrower spectrum penicillins, anti-pseudomonal penicillins and aminoglycosides were not potent inciting agents.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.120 Inflammatory Bowel Diseases & Infections
1.120.1133 Clostridium Infections
Web Of Science research areas
Infectious Diseases
Microbiology
Pharmacology & Pharmacy
ESI research areas
Pharmacology & Toxicology
Logo image